VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | Future approaches in esophageal cancer

VJOncology is committed to improving our service to you

Omkara Veeranki

Omkara Veeranki, MD, University of Texas MD Anderson Cancer Center, Houston, TX, outlines future avenues in esophageal cancer treatment, including the approval of PD-L1 inhibitors for this indication as well as drawbacks to its use. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter